Can Mitra Script Cancer Therapy Transformation?
Executive Summary
Emerging Company Profile: Mitra Biotech hopes its CANScript platform can alter the course of cancer therapy decisions for patients and optimize drug development. Mitra's co-founder, president and CEO Dr Mallikarjun Sundaram tells Scrip that the firm also has "exciting" data on the activity of immune check point inhibitors in CANScript.